Abiomed Recovering Hearts. Saving Lives
Our Company Investors News Products Clinicians Patients & Families

Press Releases
Articles
Archives

Press Contact:
Liza Heapes
Ph: 978-646-1668
Email: lheapes@abiomed.com

 
DANVERS, Mass. (May 13, 2005) - ABIOMED, Inc. (NASDAQ: ABMD) a manufacturer of products for circulatory care and support, today announced that Michael R. Minogue, Chief Executive Officer and President, is scheduled to present at the Banc of America Securities 2005 Health Care Conference. The conference is being held from May 17-19, 2005 at the Four Seasons Hotel in Las Vegas. Mr. Minogue is scheduled to present on Thursday, May 19th at 12:00 p.m., Pacific Time (3:00 p.m., Eastern Time).

Mr. Minogue’s presentation will also be available live via a webcast that can be accessed through the Company’s website: www.abiomed.com.

About ABIOMED
Based in Danvers, Massachusetts, ABIOMED, Inc. (pronounced “AB’-EE-O-MED”) is a leading developer, manufacturer and marketer of medical products designed to assist or replace the pumping function of the failing heart. ABIOMED, which currently sells the BVS® 5000 Biventricular Support System and the AB5000™ Circulatory Support System, is the market leader in devices for the temporary support of patients with failing but potentially recoverable hearts. ABIOMED is also pursuing initial FDA market approval for the AbioCor® Implantable Replacement Heart under a Humanitarian Device Exemption to treat a defined subset of irreversible end-stage heart failure patients. For additional information about ABIOMED, please visit www.abiomed.com.

###

Media Contact:
Communications Specialist
(978) 646-1419
mediarelations@abiomed.com

Investor Relations Contact:
Jane Petrino
Noonan Russi
(212) 845-4274 jane.petrino@eurorscg.com